FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker-Reference-Cited by-同舟云学术

FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker

Published:2018-08-03 Issue:60 Volume:9 Page:31637-31649
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Gouazé-Andersson Valérie¹,Ghérardi Marie-Julie¹,Lemarié Anthony¹,Gilhodes Julia²,Lubrano Vincent³,Arnauduc Florent¹,Cohen-Jonathan Moyal Elizabeth¹²,Toulas Christine¹²

Affiliation:

1. Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1037/Université Toulouse III Paul Sabatier, Cancer Research Center of Toulouse (CRCT), Toulouse, F-31000, France

2. Institut Claudius Regaud, IUCT-O, Toulouse, F-31059, France

3. CHU PURPAN-Pavillon Baudot, Place du Dr Baylac, Toulouse-Cedex 3, 31024, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DDX56 promotes EMT and cancer stemness via MELK-FOXM1 axis in hepatocellular carcinoma;iScience;2024-06

2. KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System;Cells;2024-05-29

3. KR158 spheres harboring slow-cycling cells recapitulate GBM features in an immunocompetent system;2024-01-30

4. The molecular mechanisms of drug resistance of glioblastoma: differentiation and apoptosis;Russian Journal for Personalized Medicine;2024-01-16

5. A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis;Genes & Diseases;2024-01